Navigation Links
Experimental Chemical Helps Blind Mice See
Date:7/25/2012

WEDNESDAY, July 25 (HealthDay News) -- A novel chemical temporarily restored some vision to blind mice, and this success may eventually lead to a treatment to help people with degenerative blindness see again, according to a new study.

Those who could benefit include people with retinitis pigmentosa and age-related macular degeneration (AMD). Retinitis pigmentosa is a genetic disease that is the most common inherited form of blindness, while AMD is the most common cause of acquired blindness in the developed world.

In both diseases, light sensitive cells in the retina called rods and cones die and leave the eye without functioning photoreceptors.

The mice used in this study had genetic mutations that made their rods and cones die within months of birth. Injections of the chemical AAQ into the eyes of the blind mice temporarily restored their light sensitivity, according to the study published in the July 26 issue of the journal Neuron.

AAQ makes the remaining, normally "blind" cells in the retina sensitive to light, lead researcher Richard Kramer, a professor of molecular and cell biology at the University of California, Berkeley, explained in a university news release.

This approach "offers real hope to patients with retinal degeneration," study co-author Dr. Russell Van Gelder, chair of the ophthalmology department at the University of Washington in Seattle, said in the news release.

"We still need to show that these compounds are safe and will work in people the way they work in mice, but these results demonstrate that this class of compound restores light sensitivity to retinas blind from genetic disease," he added.

The researchers noted that the chemical eventually wears off, which may make it a safer alternative to other experimental methods for restoring sight, such as gene or stem cell therapies, which permanently change the retina. Chemical treatment is also less invasive than implanting light-sensitive chips in the eye, the researchers said.

"The advantage of this approach is that it is a simple chemical, which means that you can change the dosage, you can use it in combination with other therapies, or you can discontinue the therapy if you don't like the results. As improved chemicals become available, you could offer them to patients. You can't do that when you surgically implant a chip or after you genetically modify somebody," Kramer explained.

However, experts note that while studies involving animals can be useful, they frequently fail to produce similar results in humans.

The research was supported by the U.S. National Institutes of Health's National Eye Institute and Research to Prevent Blindness.

More information

The U.S. National Eye Institute has more about age-related macular degeneration.

-- Robert Preidt

SOURCE: University of California, Berkeley, news release, July 25, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Experimental drug may extend therapeutic window for stroke
2. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
3. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
4. Experimental Vaccine Seems to Stop Nicotine Addiction in Mice
5. Experimental drug improves muscle strength among male cancer patients
6. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
7. Experimental Drug Eases Autistic Behaviors in Mice
8. Experimental Gel May Help Those With Advanced Parkinsons
9. Experimental Pill for Multiple Sclerosis Shows Promise
10. Experimental Chemo Combo for Colon Cancer Disappoints
11. American Chemical Societys highest honor to Peter Stang
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 11, 2016 , ... Florida Hospital presents Heart Health Awareness night on Sunday ... at the Amalie Arena. The puck drops at 6:00pm, but fans will have the ... prior to the game. The MEGA Heart will be located on Ford Thunder Alley ...
(Date:2/11/2016)... ... February 11, 2016 , ... The Chartis ... the top five firms in the “2015/2016 Best in KLAS: Software and Services” ... KLAS is a research and insights firm on a global mission to improve ...
(Date:2/11/2016)... ... February 11, 2016 , ... In ... Dallas plastic surgeon , Dr. Rod J. Rohrich, and colleagues, examine and ... Rohrich outlines recommendations for rhinoplasty surgeons when addressing this vital area. , The ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back ... Clarke poses a question as a challenge for his readers to examine the ... the Being" (published by Partridge Singapore), Clarke explores the subject with more depth, ...
(Date:2/11/2016)... ... February 11, 2016 , ... Colorado spine surgeon, Donald Corenman, MD, DC ... surgeons to know in 2016 . The list consists of spine surgeons across the ... , Dr. Corenman understands the importance of clinical excellence; he has been awarded the ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... de fevereiro de 2016  A Proliant Biologicals ... de soroalbumina bovina (BSA -- Bovine Serum ... na Ilha Norte da Nova Zelândia, em Feilding. ... na fábrica da Proliant nos EUA, localizada em ... e instalação dos equipamentos foram feitos de forma ...
(Date:2/11/2016)... Transformational M&A achieved through NPS and Dyax acquisitions and the ... achieved through NPS and Dyax acquisitions and the announced combination ... through NPS and Dyax acquisitions and the announced combination with ... robust pipeline in Shire , s history   ... pipeline in Shire , s history   ...
(Date:2/11/2016)... 2016 Breast Cancer Therapeutics in Asia-Pacific ... Asia-Pacific (APAC) breast cancer market will experience considerable ... 2021, at a Compound Annual Growth Rate (CAGR) of 8.5%. ... 2021 - states that the Asia-Pacific ... $1.9 billion in 2014 to $3.4 billion by 2021, at ...
Breaking Medicine Technology: